欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7793/001
药品名称Latanoprost Pharmabide
活性成分
    • Latanoprost 50.0 µg/ml
剂型Eye drops, solution in single-dose container
上市许可持有人axunio Pharma GmbH Van-der-Smissen-Strasse 1 22767 Hamburg, Germany
参考成员国 - 产品名称Germany (DE)
Latanoprost Pharmabide 50 mikrogramm/ml Augentropfen, Lösung im Einzeldosisbehältnis
互认成员国 - 产品名称
    • Greece (GR)
    • Sweden (SE)
    • Finland (FI)
    • Cyprus (CY)
      Latanoprost Pharmabide 50 micrograms/mL Eye drops, solution in single dose container
    • Denmark (DK)
      Latanoprost "Yonsung"
    • Spain (ES)
许可日期2024/05/29
最近更新日期2024/12/16
药物ATC编码
    • S01EE01 latanoprost
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase